Clinical Trial: Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomati

Brief Summary: This study is designed to assess the safety and effectiveness of the rhBMP-2/ACS/LT-CAGE® device as compared to the LT-CAGE® device with autogenous bone in patients with symptomatic degenerative disc disease using an open surgical technique.

Detailed Summary:
Sponsor: Medtronic Spinal and Biologics

Current Primary Outcome: Overall success [ Time Frame: 24 months ]

A patient will be considered an overall success if all of the following conditions are met:

  1. fusion;
  2. pain/disability (Oswestry) improvement;
  3. maintenance or improvement in neurological status;
  4. no serious adverse event classified as implant associated or implant/surgical procedure associated;
  5. no additional surgical procedure classified as a "failure."


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Disc Height Measurement [ Time Frame: 24 months ]
  • General Health Status (SF-36) [ Time Frame: 24 months ]
  • Pain Status (Numerical Rating Scale) [ Time Frame: 24 months ]
  • Patient Satisfaction [ Time Frame: 24 months ]
  • Patient Global Perceived Effect [ Time Frame: 24 months ]


Original Secondary Outcome: Same as current

Information By: Medtronic Spinal and Biologics

Dates:
Date Received: December 12, 2011
Date Started: August 1998
Date Completion:
Last Updated: August 1, 2013
Last Verified: December 2011